Cybin Inc. (NYSE AMERICAN: CYBN)
$0.31
-0.0128 ( -3.94% ) 4.9M
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
Market Data
Open
$0.31
Previous close
$0.32
Volume
4.9M
Market cap
$239.31M
Day range
$0.30 - $0.33
52 week range
$0.25 - $0.74
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 3 | Dec 05, 2023 |
| 6-k | Quarterly Reports | 4 | Nov 30, 2023 |
| 6-k | Quarterly Reports | 3 | Nov 21, 2023 |
| 6-k | Quarterly Reports | 3 | Nov 21, 2023 |
| 6-k | Quarterly Reports | 3 | Nov 16, 2023 |
| 6-k | Quarterly Reports | 9 | Nov 15, 2023 |
| 6-k | Quarterly Reports | 3 | Nov 15, 2023 |
| 6-k | Quarterly Reports | 3 | Nov 14, 2023 |
| 6-k/a | Quarterly Reports | 1 | Nov 13, 2023 |
| 6-k/a | Quarterly Reports | 7 | Nov 13, 2023 |